Cognitive Impairment
📧 Sign up to get email alerts when something new happens for Cognitive Impairment.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-10-11Clinical Trial Update: The Use of Duloxetine for Cognition Improvement in Individuals With Mild Cognitive Impairment [Phase 4]
Phase 4 trial update evaluating duloxetine for cognition improvement in mild cognitive impairment with comorbid depression has been complete…
-
CLINICAL_TRIALS trial_result · 2018-10-02Clinical Trial Update: Specialized Food Plan Based on Individual Physiological Comprehensive Body Assessments Accompanied With Cellular Repair Therapy to Decrease Inflammation Cognitively Impaired Patients [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating a specialized diet plan combined with cellular repair therapy to reduce inflammation in patients with mi…
-
CLINICAL_TRIALS trial_result · 2018-08-31Clinical Trial Update: Enhancing Spatial Navigation Using Non-Invasive Brain Stimulation [NA]
A completed clinical trial investigated non-invasive brain stimulation to enhance spatial navigation in individuals with mild cognitive impa…
-
CLINICAL_TRIALS trial_result · 2018-08-27Clinical Trial Update: Guilingji Capsule for Mild-to-moderate Cognitive Impairment [Phase 2]
Phase 2 clinical trial update for Guilingji Capsule in mild-to-moderate cognitive impairment (cognitive dysfunction).
-
CLINICAL_TRIALS trial_result · 2018-08-23Clinical Trial Update: Atomoxetine Treatment for Cognitive Impairment in Parkinson's Disease (ATM-Cog) [Phase 2]
Phase 2 trial update for atomoxetine in cognitive impairment associated with Parkinson's disease has completed with results posted in 2018.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-07-27Clinical Trial Update: NEURoaid II (MLC 901) Assessment in Cognitively Impaired Not Demented Subjects [Phase 2]
Phase 2 clinical trial of NEURoaid II (MLC 901) assessing cognitive outcomes in cognitively impaired non-demented subjects has completed.
-
CLINICAL_TRIALS research · 2018-07-26Clinical Trial Update: Aging Stereotypes and Prodromal Alzheimer's Disease [NA]
Clinical trial update on aging stereotypes and prodromal Alzheimer's disease with Mild Cognitive Impairment as the condition; current status…
-
CLINICAL_TRIALS trial_result · 2018-07-23Clinical Trial Update: Efficacy And Safety Of CX516 In Elderly Participants With Mild Cognitive Impairment. [Phase 2]
A Phase 2 trial evaluating the efficacy and safety of CX516 in elderly participants with mild cognitive impairment has completed, with resul…
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: Imaging the Neural Network Connectivity on Patients With Mild Cognitive Impairment
A completed clinical trial (NCT01927653) investigating imaging of neural network connectivity in patients with Mild Cognitive Impairment.
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: Systems Biology Approach to Cognitive Impairment After SepsiS
A completed clinical trial investigating a systems biology approach to cognitive impairment following sepsis.
-
CLINICAL_TRIALS trial_result · 2018-07-11Clinical Trial Update: Physical Activity and Neuropsychological Outcomes in a Cancer Population [NA]
A completed clinical trial examined the impact of physical activity on neuropsychological outcomes in breast cancer survivors with cognitive…
-
FDA approval · 2018-07-10FDA Approved: NEURACEQ — Supplemental Application (Lantheus Biosciences Ltd.)
FDA approved a supplemental application for NEURACEQ (Florbetaben F-18) from Lantheus Biosciences Ltd.
-
CLINICAL_TRIALS research · 2018-07-10Clinical Trial Update: Validation of the Montreal Cognitive Assessment in Patients With Mild and Major Neurocognitive Disorder
A completed clinical trial evaluating the Montreal Cognitive Assessment for validity in patients with mild and major neurocognitive disorder…
-
CLINICAL_TRIALS trial_result · 2018-06-14Clinical Trial Update: Clinical Evaluation of Florbetapir F 18 (18F-AV-45) [Phase 2]
Phase 2 clinical evaluation of Florbetapir F-18 (18F-AV-45) completed; results posted.
-
CLINICAL_TRIALS trial_result · 2018-06-08Clinical Trial Update: Memory and Attention Disorders and Malnutrition in Hospital Setting
This clinical trial update indicates the study on memory and attention disorders and malnutrition in hospitalized patients has completed, wi…
-
CLINICAL_TRIALS research · 2018-06-04Clinical Trial Update: Renji Cerebral Small Vessel Disease Corhort Study
Clinical trial update from Renji Hospital for a cohort study on cerebral small vessel disease; the current status of the trial is unknown.
-
CLINICAL_TRIALS research · 2018-05-31Clinical Trial Update: Normative Values for the German Version of the Montreal Cognitive Assessment (MoCA)
This clinical trial update provides normative data for the German version of the Montreal Cognitive Assessment (MoCA).
-
CLINICAL_TRIALS research · 2018-05-25Clinical Trial Update: Appropriate Compatibility of Propofol and Sevoflurane for Orthopaedic Surgery of Patients With MCI [NA]
A clinical trial update assessing the compatibility of propofol and sevoflurane anesthesia for orthopaedic surgery in patients with mild cog…
-
CLINICAL_TRIALS research · 2018-05-22Clinical Trial Update: Beam Walking Across the Lifespan for Falls Prediction
The trial examines beam walking across the lifespan as a predictor of falls, sponsored by University Medical Center Groningen, focusing on a…
-
CLINICAL_TRIALS research · 2018-05-21Clinical Trial Update: To Explore Cognitive Neural Mechanism of Autoimmune Encephalitis by Using Neuropsychological Tests and Multi-modal MRI
A completed clinical trial investigating cognitive neural mechanisms of autoimmune encephalitis using neuropsychological tests and multi-mod…
-
CLINICAL_TRIALS trial_result · 2018-05-18Clinical Trial Update: Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease [Phase 1, Phase 2]
A Phase 1/Phase 2 study of LY2886721 for mild cognitive impairment due to Alzheimer's disease or mild Alzheimer's disease was terminated; re…
-
CLINICAL_TRIALS research · 2018-05-18Clinical Trial Update: Neurofeedback Training for Older Adults With Mild Cognitive Impairment: a Protocol Study [NA]
Overview of a protocol for a clinical trial evaluating neurofeedback training in older adults with mild cognitive impairment.
-
CLINICAL_TRIALS trial_result · 2018-05-11Clinical Trial Update: Group Reminiscence Therapy for Elderly People With Cognitive Decline in Institutional Context [NA]
This document reports an update on a clinical trial evaluating group reminiscence therapy for elderly individuals with cognitive decline or …
-
CLINICAL_TRIALS research · 2018-05-03Clinical Trial Update: The Aerobic & Cognitive Exercise Study [NA]
The Aerobic & Cognitive Exercise Study (NCT02237560), sponsored by Union College, New York, has completed its trial evaluating aerobic and c…
-
CLINICAL_TRIALS research · 2018-05-03Clinical Trial Update: Rehabilitation of Working Memory and Brain Plasticity After Traumatic Brain Injury: Plastim-MDTC [NA]
A clinical trial is investigating rehabilitation of working memory and brain plasticity after traumatic brain injury, using Plastim-MDTC. Th…